Funder
AstraZeneca
U.S. Department of Defense
Defense Advanced Research Projects Agency
Reference64 articles.
1. Muromonab-CD3 (Orthoclone OKT3): the first monoclonal antibody approved for therapeutic use;Emmons;Iowa Med.,1987
2. FDA approves 100th monoclonal antibody product;Mullard;Nat. Rev. Drug Discov.,2021
3. Antibodies to watch in 2022;Kaplon;MAbs,2022
4. How mRNA therapeutics are entering the monoclonal antibody field;Van Hoecke;J. Transl. Med.,2019
5. In vivo expressed biologics for infectious disease prophylaxis: rapid delivery of DNA-based antiviral antibodies;Andrews;Emerg. Microbes Infect.,2020